Jesus S. Miguel
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025).
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 08, 2026
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).
Journal: Research square
Published: June 12, 2025
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison.
Journal: Advances in therapy
Published: January 29, 2025
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Journal: Haematologica
Published: April 23, 2024
Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis.
Journal: Haematologica
Published: October 04, 2023
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity.
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 21, 2023
Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: What we learned, and how it will impact scientific discovery and patient care.
Journal: Seminars in hematology
Published: May 18, 2023
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Journal: Blood cancer journal
Published: August 18, 2021
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
Journal: The Lancet. Haematology
Published: June 05, 2021
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.
Journal: Haematologica
Published: March 12, 2021
Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.
Journal: Haematologica
Published: October 15, 2020
Last Updated: 09/26/2026